Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Harrison

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Expert Review of Anti-Infective Therapy|October 23, 2015
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunizationBenjamin W Teh, Monica A Slavin, Simon J Harrison, et al.
Leukemia & Lymphoma|December 4, 2020
Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literatureGemma Reynolds, Tamasine Stewart, Simon J Harrison, et al.
Blood Reviews|March 7, 2021
Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gapAnthony P Longhitano, Monica A Slavin, Simon J Harrison, et al.
Leukemia & Lymphoma|November 18, 2024
Infections during novel myeloma therapiesAlice J Liu, Monica A Slavin, Simon J Harrison, et al.
Cancer Nursing|August 18, 2016
Physical Activity Preferences for People Living With Multiple Myeloma: A Qualitative StudyMelinda Craike, Kaye Hose, Kerry S Courneya, et al.
BMC Cancer|July 3, 2013
Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: a qualitative studyMelinda J Craike, Kaye Hose, Kerry S Courneya, et al.
European Journal of Haematology|November 2, 2022
Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapyRithin Nedumannil, David Ritchie, Ashish Bajel, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 26, 2015
Outcome of the Stryker® Trident 'All-Poly' constraint acetabular insert: a district general hospital experienceSimon J Harrison, Daniel J Leeder, Timothy G McWilliams, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 10, 2014
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer HospitalBenjamin W Teh, Leon J Worth, Simon J Harrison, et al.
Mycoses|September 5, 2020
Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort studyChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Expert Review of Anti-Infective Therapy|October 23, 2015
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunizationBenjamin W Teh, Monica A Slavin, Simon J Harrison, et al.
Leukemia & Lymphoma|December 4, 2020
Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literatureGemma Reynolds, Tamasine Stewart, Simon J Harrison, et al.
Blood Reviews|March 7, 2021
Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gapAnthony P Longhitano, Monica A Slavin, Simon J Harrison, et al.
Leukemia & Lymphoma|November 18, 2024
Infections during novel myeloma therapiesAlice J Liu, Monica A Slavin, Simon J Harrison, et al.
Cancer Nursing|August 18, 2016
Physical Activity Preferences for People Living With Multiple Myeloma: A Qualitative StudyMelinda Craike, Kaye Hose, Kerry S Courneya, et al.
BMC Cancer|July 3, 2013
Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: a qualitative studyMelinda J Craike, Kaye Hose, Kerry S Courneya, et al.
European Journal of Haematology|November 2, 2022
Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapyRithin Nedumannil, David Ritchie, Ashish Bajel, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 26, 2015
Outcome of the Stryker® Trident 'All-Poly' constraint acetabular insert: a district general hospital experienceSimon J Harrison, Daniel J Leeder, Timothy G McWilliams, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 10, 2014
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer HospitalBenjamin W Teh, Leon J Worth, Simon J Harrison, et al.
Mycoses|September 5, 2020
Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort studyChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Pageof 16